확장 가능한 3D 엔지니어링 근육 조직의 전임상 약물 테스트
3,303 Views
•
08:07 min
•
April 07, 2023
DOI:
Summary
Automatically generated
이 프로토콜은 3D 엔지니어링된 심장 및 골격근 조직을 생성하는 방법을 제공하고 전임상 약물 스크리닝 양식에서의 사용을 설명합니다. 설명된 방법은 자기 감지 시스템을 사용하여 24개의 조직을 동시에 동시에 평가할 수 있습니다.
Related Videos
08:38
Engineering Skeletal Muscle Tissues from Murine Myoblast Progenitor Cells and Application of Electrical Stimulation
Related Videos
20962 Views
11:12
Tissue Engineering of a Human 3D in vitro Tumor Test System
Related Videos
21330 Views
10:03
Physiologic Patient Derived 3D Spheroids for Anti-neoplastic Drug Screening to Target Cancer Stem Cells
Related Videos
8749 Views
13:34
A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
Related Videos
10162 Views
10:39
Automated Contraction Analysis of Human Engineered Heart Tissue for Cardiac Drug Safety Screening
Related Videos
12728 Views
11:28
3D Microtissues for Injectable Regenerative Therapy and High-throughput Drug Screening
Related Videos
10262 Views
10:37
Fabrication of 3D Cardiac Microtissue Arrays using Human iPSC-Derived Cardiomyocytes, Cardiac Fibroblasts, and Endothelial Cells
Related Videos
6401 Views
09:30
Assessing Functional Metrics of Skeletal Muscle Health in Human Skeletal Muscle Microtissues
Related Videos
4007 Views
11:07
Engineering and Characterization of an Optogenetic Model of the Human Neuromuscular Junction
Related Videos
2336 Views
09:23
Generation, High-Throughput Screening, and Biobanking of Human-Induced Pluripotent Stem Cell-Derived Cardiac Spheroids
Related Videos
3676 Views
Read Article
Cite this Article
Berry, B. J., Luttrell, S. M., Moerk, C. T., Macadangdang, J., Perez, J., Gray, K., Ghazizadeh, H., Kharoufeh, S., Nelsen, B., Geisse, N. A. Preclinical Drug Testing in Scalable 3D Engineered Muscle Tissues. J. Vis. Exp. (194), e64399, doi:10.3791/64399 (2023).
Copy